Previously, hyperhomocysteinemia accelerates AKI to CKD progression by downregulating heme oxygenase-1 (HO-1) expression [18]; consistently, the HO-1 levels were reduced by Hcy treatment in IR mice (Figure 3C). The gene discussed is HMOX1; the disease is hyperhomocysteinemia.